Header Logo

Duc Ha

Concepts (100)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension
8
2026
609
1.260
 Why?
Vietnam
16
2026
177
0.970
 Why?
Rural Population
4
2026
221
0.790
 Why?
Noncommunicable Diseases
2
2019
18
0.750
 Why?
Cardiovascular Diseases
4
2020
859
0.730
 Why?
Cancer Survivors
1
2021
126
0.610
 Why?
Stakeholder Participation
1
2019
29
0.590
 Why?
Lung Neoplasms
1
2021
706
0.440
 Why?
Risk Reduction Behavior
1
2010
121
0.310
 Why?
Life Style
2
2024
320
0.310
 Why?
Primary Prevention
1
2010
136
0.300
 Why?
Prevalence
5
2026
1432
0.290
 Why?
Health Knowledge, Attitudes, Practice
1
2013
768
0.280
 Why?
Community Health Workers
2
2020
41
0.260
 Why?
Cost-Benefit Analysis
3
2020
315
0.250
 Why?
Quality of Life
2
2026
1257
0.250
 Why?
Myocardial Infarction
3
2022
916
0.240
 Why?
Fibrinolytic Agents
1
2026
174
0.220
 Why?
Time-to-Treatment
1
2026
133
0.220
 Why?
Thrombolytic Therapy
1
2026
195
0.220
 Why?
Depression, Postpartum
1
2026
120
0.210
 Why?
Humans
19
2026
64792
0.190
 Why?
Text Messaging
1
2024
95
0.190
 Why?
Adult
8
2026
17247
0.180
 Why?
Developing Countries
2
2019
87
0.180
 Why?
Clinical Laboratory Services
1
2021
5
0.180
 Why?
Medical Laboratory Personnel
1
2021
10
0.170
 Why?
Income
2
2019
170
0.170
 Why?
Air Travel
1
2021
3
0.170
 Why?
Contact Tracing
1
2021
17
0.170
 Why?
Middle Aged
11
2026
18122
0.170
 Why?
ST Elevation Myocardial Infarction
1
2022
95
0.160
 Why?
Data Collection
2
2019
381
0.160
 Why?
Patients
1
2021
114
0.160
 Why?
Surveys and Questionnaires
2
2021
2754
0.160
 Why?
Aged
10
2026
14847
0.150
 Why?
Endovascular Procedures
1
2026
624
0.150
 Why?
Female
13
2026
33769
0.150
 Why?
Smoking Cessation
1
2024
552
0.140
 Why?
Cross-Sectional Studies
2
2026
2679
0.140
 Why?
Male
12
2026
30810
0.140
 Why?
Clinical Trials as Topic
1
2021
460
0.140
 Why?
Hospital Administration
2
2014
43
0.130
 Why?
Pneumonia, Ventilator-Associated
1
2017
37
0.130
 Why?
Randomized Controlled Trials as Topic
1
2020
798
0.120
 Why?
Drug Resistance, Bacterial
1
2017
95
0.120
 Why?
Lung
1
2021
965
0.120
 Why?
Biomedical Research
1
2019
270
0.120
 Why?
Health Behavior
1
2018
482
0.110
 Why?
Patient Education as Topic
1
2018
480
0.110
 Why?
Clinical Protocols
1
2016
134
0.110
 Why?
Health Education
1
2016
191
0.110
 Why?
Intensive Care Units
1
2017
419
0.100
 Why?
Sex Factors
2
2014
987
0.100
 Why?
Comorbidity
2
2014
1115
0.100
 Why?
Treatment Outcome
4
2026
5757
0.100
 Why?
Sex Characteristics
1
2014
211
0.090
 Why?
Aged, 80 and over
4
2021
5575
0.090
 Why?
Overweight
1
2013
253
0.080
 Why?
Anti-Bacterial Agents
1
2017
801
0.080
 Why?
Risk Factors
3
2026
5396
0.080
 Why?
Health Status Indicators
1
2010
94
0.080
 Why?
Hospitalization
2
2014
1384
0.080
 Why?
Age Factors
1
2013
1580
0.070
 Why?
Early Ambulation
1
2026
10
0.060
 Why?
Time Factors
2
2026
3744
0.060
 Why?
Disability Evaluation
1
2026
216
0.050
 Why?
Recovery of Function
1
2026
290
0.050
 Why?
Hotlines
1
2024
21
0.050
 Why?
Blood Pressure
1
2026
525
0.050
 Why?
Peer Group
1
2024
109
0.050
 Why?
Social Support
1
2026
388
0.050
 Why?
Anxiety
1
2026
423
0.050
 Why?
Registries
1
2026
896
0.040
 Why?
Alcohol Drinking
1
2024
322
0.040
 Why?
Shock, Cardiogenic
1
2022
107
0.040
 Why?
Pandemics
1
2026
668
0.040
 Why?
Health Promotion
1
2024
512
0.040
 Why?
Hospitals
1
2022
385
0.040
 Why?
Smoking
1
2024
860
0.040
 Why?
Patient Compliance
1
2021
365
0.040
 Why?
Risk Assessment
1
2026
2089
0.040
 Why?
Hospital Mortality
1
2022
871
0.030
 Why?
Ceftazidime
1
2017
1
0.030
 Why?
Imipenem
1
2017
5
0.030
 Why?
Acinetobacter baumannii
1
2017
6
0.030
 Why?
beta-Lactams
1
2017
12
0.030
 Why?
Acinetobacter Infections
1
2017
7
0.030
 Why?
Klebsiella
1
2017
10
0.030
 Why?
Ciprofloxacin
1
2017
25
0.030
 Why?
Pseudomonas Infections
1
2017
74
0.030
 Why?
Microbial Sensitivity Tests
1
2017
208
0.030
 Why?
Pseudomonas aeruginosa
1
2017
132
0.030
 Why?
Young Adult
1
2026
4777
0.030
 Why?
Culture
1
2016
80
0.030
 Why?
Data Interpretation, Statistical
1
2016
194
0.030
 Why?
Retrospective Studies
1
2026
6800
0.030
 Why?
Follow-Up Studies
1
2018
2484
0.020
 Why?
Pilot Projects
1
2014
1002
0.020
 Why?
Prognosis
1
2014
1777
0.020
 Why?
Ha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_